Clinical trials
Schizophrenia trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2007 | 6 |
| 2008 | 6 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Terminated | 5 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 6 |
| Janssen-Cilag International NV | 5 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 |
| AstraZeneca | 3 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 3 |
| Boehringer Ingelheim | 2 |
| Eli Lilly and Company | 2 |
| UMC Utrecht | 2 |
| Bristol-Myers Squibb | 1 |
| Cerevel Therapeutics, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 44 |
| Psychotic Disorders | 11 |
| Bipolar Disorder | 4 |
| Mental Disorders | 2 |
| Alzheimer Disease | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Autistic Disorder | 1 |
| Cognition Disorders | 1 |
| Cognitive Dysfunction | 1 |
| Dementia | 1 |
Trials
Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.